This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Feb;95(2):505-8.

doi: 10.1210/jc.2009-2450.

Off-label use of recombinant igf-I to promote growth: is it appropriate?

Arlan L Rosenbloom, Scott A Rivkees

PMID: 20133470
DOI: 10.1210/jc.2009-2450

Editorial

Off-label use of recombinant igf-I to promote growth: is it appropriate?

Arlan L Rosenbloom et al. J Clin Endocrinol Metab. 2010 Feb.

. 2010 Feb;95(2):505-8.

doi: 10.1210/jc.2009-2450.

Authors

Arlan L Rosenbloom, Scott A Rivkees

PMID: 20133470
DOI: 10.1210/jc.2009-2450

No abstract available

PubMed Disclaimer

Similar articles

Mecasermin (recombinant human insulin-like growth factor I).
Rosenbloom AL. Rosenbloom AL. Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Adv Ther. 2009. PMID: 19198769 Review.
Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
Rosenthal S, Cohen P, Clayton P, Backeljauw P, Bang P, Ten S. Rosenthal S, et al. Pediatr Endocrinol Rev. 2007 May;4 Suppl 2:252-71. Pediatr Endocrinol Rev. 2007. PMID: 17581497 Review. No abstract available.
Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
Ranke MB, Wollmann HA, Savage MO. Ranke MB, et al. J Pediatr Endocrinol Metab. 1999 Apr;12 Suppl 1:259-66. J Pediatr Endocrinol Metab. 1999. PMID: 10698590 Review. No abstract available.
Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
Bright GM, Mendoza JR, Rosenfeld RG. Bright GM, et al. Endocrinol Metab Clin North Am. 2009 Sep;38(3):625-38. doi: 10.1016/j.ecl.2009.06.003. Endocrinol Metab Clin North Am. 2009. PMID: 19717008 Review.
Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans.
Backeljauw PF, Chernausek SD. Backeljauw PF, et al. Horm Res. 2006;65 Suppl 1:21-7. doi: 10.1159/000090643. Epub 2006 Mar 2. Horm Res. 2006. PMID: 16508330 Review. No abstract available.

See all similar articles

Cited by

Neurotrophic and Neuroregenerative Effects of GH/IGF1.
Bianchi VE, Locatelli V, Rizzi L. Bianchi VE, et al. Int J Mol Sci. 2017 Nov 17;18(11):2441. doi: 10.3390/ijms18112441. Int J Mol Sci. 2017. PMID: 29149058 Free PMC article. Review.
Natural fish oil improves the differentiation and maturation of oligodendrocyte precursor cells to oligodendrocytes in vitro after interaction with the blood-brain barrier.
Piatek P, Lewkowicz N, Michlewska S, Wieczorek M, Bonikowski R, Parchem K, Lewkowicz P, Namiecinska M. Piatek P, et al. Front Immunol. 2022 Jul 22;13:932383. doi: 10.3389/fimmu.2022.932383. eCollection 2022. Front Immunol. 2022. PMID: 35935952 Free PMC article.
The Effect of Insulin Like Growth Factor-1 on Recovery of Facial Nerve Crush Injury.
Bayrak AF, Olgun Y, Ozbakan A, Aktas S, Kulan CA, Kamaci G, Demir E, Yilmaz O, Olgun L. Bayrak AF, et al. Clin Exp Otorhinolaryngol. 2017 Dec;10(4):296-302. doi: 10.21053/ceo.2016.00997. Epub 2017 Mar 8. Clin Exp Otorhinolaryngol. 2017. PMID: 28264555 Free PMC article.
Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases.
Ahmad SS, Ahmad K, Lee EJ, Lee YH, Choi I. Ahmad SS, et al. Cells. 2020 Jul 24;9(8):1773. doi: 10.3390/cells9081773. Cells. 2020. PMID: 32722232 Free PMC article. Review.
Comprehensive Analysis of Uric Acid and Myasthenia Gravis: IGF1R as a Protective Factor and Potential Therapeutic Target.
Shen Y, Pang L, Wang H, Han Q, Wan W, Luo S, Song Z, Fang Y, Chen H, Qiu Y, Tan D, Zhou M, Hong D. Shen Y, et al. CNS Neurosci Ther. 2025 Mar;31(3):e70361. doi: 10.1111/cns.70361. CNS Neurosci Ther. 2025. PMID: 40152081 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information